Exact Mass: 460.259
Exact Mass Matches: 460.259
Found 500 metabolites which its exact mass value is equals to given mass value 460.259
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Sophoranone
A dihydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 7 and 4 and prenyl groups at positions 3 and 5 respectively.
4,4-Diapolycopene-4,4-dioate
1-(8Z,11Z,14Z-eicosatrienoyl)-glycero-3-phosphate
1-(8Z,11Z,14Z-eicosatrienoyl)-glycero-3-phosphate is classified as a member of the 1-acylglycerol-3-phosphates. 1-acylglycerol-3-phosphates are lysophosphatidic acids where the glycerol is esterified with a fatty acid at O-1 position. 1-(8Z,11Z,14Z-eicosatrienoyl)-glycero-3-phosphate is considered to be practically insoluble (in water) and acidic. 1-(8Z,11Z,14Z-eicosatrienoyl)-glycero-3-phosphate is a glycerophosphate lipid molecule
LysoPA(20:3(5Z,8Z,11Z)/0:0)
LysoPA(20:3(5Z,8Z,11Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(20:3(5Z,8Z,11Z)/0:0), in particular, consists of one chain of mead acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
LysoPA(20:3(8Z,11Z,14Z)/0:0)
LysoPA(20:3(8Z,11Z,14Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(20:3(8Z,11Z,14Z)/0:0), in particular, consists of one chain of dihomo-gamma-linolenic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
Fluocortolone Pivalate
2,3-Dihydro-11,11-bis(3-methyl-2-butenyl)-5,6-dihydroxy-2,2,3,8-tetramethylanthra[2,3-b]furan-4(11H)-one
Rudbeckiolide
Sanggenofuran A
Munchiwarin
Sophoradin
(1aR,2E,4aR,6S,7S,7aR,8R,11aS)-1,1,3,6-Tetramethyl-9-methylene-4-oxo-1,1a,4,5,6,7,7a,8,9,10,11,11a-dodecahydro-4aH-cyclopenta[a]cyclopropa[f][11]annulene-4a,7,8-triyl triacetate
(2S)-3,4-dihydro-7-hydroxy-2,2-dimethyl-8,8-bis(3-methylbut-2-enyl)-[2,6-bi-2H-1-benzopyran]-4(3H)-one|tokinochromane B
Daigredorigenin|daigredorigenin 3-acetate|daigredorigenin-3-acetate
6-[1-hydroxy-3-(4-hydroxyphenyl)allylidene]-2,2,4-tris(3-methylbut-2-enyl)cyclohex-4-ene-1,3-dione|munchiwarin
3beta-angeloyloxy-6beta-(3-methylpentanoyloxy)furanoeremophilan-14-oic acid
1-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-3-[4-hydroxy-3,5-bis(3-methylbut-2-enyl)phenyl]prop-2-en-1-one
(2S)-2-[3,4-dihydro-2,2-dimethyl-8-(3-methylbut-2-enyl)-2H-1-benzopyran-6-yl]-2,3,9,10-tetrahydro-8,8-dimethyl-4H,8H-benzo[1,2-b:3,4-b]dipyran-4-one|tokinochromane A
12-amino-9-sec-butyl-6-(1-hydroxy-1-methyl-propyl)-15-methoxy-4,7,10-triaza-bicyclo[12.3.1]octadeca-1(18),2,14,16-tetraene-5,8,11-trione|Zizyphine E|Zizyphine-E
Ser Ile Asn Lys
Ser Gln Val Lys
4-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentylamino]-4-oxobutanoic acid
4-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentylamino]-4-oxobutanoic acid
4-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentylamino]-4-oxobutanoic acid [IIN-based: Match]
4-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentylamino]-4-oxobutanoic acid [IIN-based on: CCMSLIB00000845587]
Ala Asp Lys Lys
Ala Lys Asp Lys
Ala Lys Lys Asp
Asp Ala Lys Lys
Asp Ile Ile Thr
Asp Ile Leu Thr
Asp Ile Thr Ile
Asp Ile Thr Leu
Asp Lys Ala Lys
Asp Lys Lys Ala
Asp Leu Ile Thr
Asp Leu Leu Thr
Asp Leu Thr Ile
Asp Leu Thr Leu
Asp Thr Ile Ile
Asp Thr Ile Leu
Asp Thr Leu Ile
Asp Thr Leu Leu
Glu Gly Lys Lys
Glu Ile Ile Ser
Glu Ile Leu Ser
Glu Ile Ser Ile
Glu Ile Ser Leu
Glu Ile Thr Val
Glu Ile Val Thr
Glu Lys Gly Lys
Glu Lys Lys Gly
Glu Leu Ile Ser
Glu Leu Leu Ser
Glu Leu Ser Ile
Glu Leu Ser Leu
Glu Leu Thr Val
Glu Leu Val Thr
Glu Ser Ile Ile
Glu Ser Ile Leu
Glu Ser Leu Ile
Glu Ser Leu Leu
Glu Thr Ile Val
Glu Thr Leu Val
Glu Thr Val Ile
Glu Thr Val Leu
Glu Val Ile Thr
Glu Val Leu Thr
Glu Val Thr Ile
Glu Val Thr Leu
Phe Pro Val Val
Phe Val Pro Val
Phe Val Val Pro
Gly Glu Lys Lys
Gly Lys Glu Lys
Gly Lys Lys Glu
Ile Asp Ile Thr
Ile Asp Leu Thr
Ile Asp Thr Ile
Ile Asp Thr Leu
Ile Glu Ile Ser
Ile Glu Leu Ser
Ile Glu Ser Ile
Ile Glu Ser Leu
Ile Glu Thr Val
Ile Glu Val Thr
Ile Ile Asp Thr
Ile Ile Glu Ser
Ile Ile Ser Glu
Ile Ile Thr Asp
Ile Lys Asn Ser
Ile Lys Ser Asn
Ile Leu Asp Thr
Ile Leu Glu Ser
Ile Leu Ser Glu
Ile Leu Thr Asp
Ile Asn Lys Ser
Ile Asn Ser Lys
Ile Ser Glu Ile
Ile Ser Glu Leu
Ile Ser Ile Glu
Ile Ser Lys Asn
Ile Ser Leu Glu
Ile Ser Asn Lys
Ile Thr Asp Ile
Ile Thr Asp Leu
Ile Thr Glu Val
Ile Thr Ile Asp
Ile Thr Leu Asp
Ile Thr Val Glu
Ile Val Glu Thr
Ile Val Thr Glu
Lys Ala Asp Lys
Lys Ala Lys Asp
Lys Asp Ala Lys
Lys Asp Lys Ala
Lys Glu Gly Lys
Lys Glu Lys Gly
Lys Gly Glu Lys
Lys Gly Lys Glu
Lys Ile Asn Ser
Lys Ile Ser Asn
Lys Lys Ala Asp
Lys Lys Asp Ala
Lys Lys Glu Gly
Lys Lys Gly Glu
Lys Leu Asn Ser
Lys Leu Ser Asn
Lys Asn Ile Ser
Lys Asn Leu Ser
Lys Asn Ser Ile
Lys Asn Ser Leu
Lys Asn Thr Val
Lys Asn Val Thr
Lys Gln Ser Val
Lys Gln Val Ser
Lys Ser Ile Asn
Lys Ser Leu Asn
Lys Ser Asn Ile
Lys Ser Asn Leu
Lys Ser Gln Val
Lys Ser Val Gln
Lys Thr Asn Val
Lys Thr Val Asn
Lys Val Asn Thr
Lys Val Gln Ser
Lys Val Ser Gln
Lys Val Thr Asn
Leu Asp Ile Thr
Leu Asp Leu Thr
Leu Asp Thr Ile
Leu Asp Thr Leu
Leu Glu Ile Ser
Leu Glu Leu Ser
Leu Glu Ser Ile
Leu Glu Ser Leu
Leu Glu Thr Val
Leu Glu Val Thr
Leu Ile Asp Thr
Leu Ile Glu Ser
Leu Ile Ser Glu
Leu Ile Thr Asp
Leu Lys Asn Ser
Leu Lys Ser Asn
Leu Leu Asp Thr
Leu Leu Glu Ser
Leu Leu Ser Glu
Leu Leu Thr Asp
Leu Asn Lys Ser
Leu Asn Ser Lys
Leu Ser Glu Ile
Leu Ser Glu Leu
Leu Ser Ile Glu
Leu Ser Lys Asn
Leu Ser Leu Glu
Leu Ser Asn Lys
Leu Thr Asp Ile
Leu Thr Asp Leu
Leu Thr Glu Val
Leu Thr Ile Asp
Leu Thr Leu Asp
Leu Thr Val Glu
Leu Val Glu Thr
Leu Val Thr Glu
Asn Ile Lys Ser
Asn Ile Ser Lys
Asn Lys Ile Ser
Asn Lys Leu Ser
Asn Lys Ser Ile
Asn Lys Ser Leu
Asn Lys Thr Val
Asn Lys Val Thr
Asn Leu Lys Ser
Asn Leu Ser Lys
Asn Ser Ile Lys
Asn Ser Lys Ile
Asn Ser Lys Leu
Asn Ser Leu Lys
Asn Thr Lys Val
Asn Thr Val Lys
Asn Val Lys Thr
Asn Val Thr Lys
Pro Phe Val Val
Pro Val Phe Val
Pro Val Val Phe
Gln Lys Ser Val
Gln Lys Val Ser
Gln Ser Lys Val
Gln Ser Val Lys
Gln Val Lys Ser
Gln Val Ser Lys
Ser Glu Ile Ile
Ser Glu Ile Leu
Ser Glu Leu Ile
Ser Glu Leu Leu
Ser Ile Glu Ile
Ser Ile Glu Leu
Ser Ile Ile Glu
Ser Ile Lys Asn
Ser Ile Leu Glu
Ser Lys Ile Asn
Ser Lys Leu Asn
Ser Lys Asn Ile
Ser Lys Asn Leu
Ser Lys Gln Val
Ser Lys Val Gln
Ser Leu Glu Ile
Ser Leu Glu Leu
Ser Leu Ile Glu
Ser Leu Lys Asn
Ser Leu Leu Glu
Ser Leu Asn Lys
Ser Asn Ile Lys
Ser Asn Lys Ile
Ser Asn Lys Leu
Ser Asn Leu Lys
Ser Gln Lys Val
Ser Val Lys Gln
Ser Val Gln Lys
Thr Asp Ile Ile
Thr Asp Ile Leu
Thr Asp Leu Ile
Thr Asp Leu Leu
Thr Glu Ile Val
Thr Glu Leu Val
Thr Glu Val Ile
Thr Glu Val Leu
Thr Ile Asp Ile
Thr Ile Asp Leu
Thr Ile Glu Val
Thr Ile Ile Asp
Thr Ile Leu Asp
Thr Ile Val Glu
Thr Lys Asn Val
Thr Lys Val Asn
Thr Leu Asp Ile
Thr Leu Asp Leu
Thr Leu Glu Val
Thr Leu Ile Asp
Thr Leu Leu Asp
Thr Leu Val Glu
Thr Asn Lys Val
Thr Asn Val Lys
Thr Val Glu Ile
Thr Val Glu Leu
Thr Val Ile Glu
Thr Val Lys Asn
Thr Val Leu Glu
Thr Val Asn Lys
Val Glu Ile Thr
Val Glu Leu Thr
Val Glu Thr Ile
Val Glu Thr Leu
Val Phe Pro Val
Val Phe Val Pro
Val Ile Glu Thr
Val Ile Thr Glu
Val Lys Asn Thr
Val Lys Gln Ser
Val Lys Ser Gln
Val Lys Thr Asn
Val Leu Glu Thr
Val Leu Thr Glu
Val Asn Lys Thr
Val Asn Thr Lys
Val Pro Phe Val
Val Pro Val Phe
Val Gln Lys Ser
Val Gln Ser Lys
Val Ser Lys Gln
Val Ser Gln Lys
Val Thr Glu Ile
Val Thr Glu Leu
Val Thr Ile Glu
Val Thr Lys Asn
Val Thr Leu Glu
Val Thr Asn Lys
Val Val Phe Pro
Val Val Pro Phe
Entereg
C78272 - Agent Affecting Nervous System > C681 - Opiate Antagonist D005765 - Gastrointestinal Agents Alvimopan dihydrate (ADL 8-2698 dihydrate) is a potent, selective, orally active and reversible μ-opioid receptor antagonist, with an IC50 of 1.7 nM. Alvimopan dihydrate has selectivity for μ-opioid receptor (Ki=0.47 nM) over κ- and δ-opioid receptors (Kis=100, 12 nM, respectively). Alvimopan dihydrate can be used for the research of postoperative ileus[1][2][3].
(S,Z)-5-Amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one
Acetylphenylalanyl-prolyl-boroarginine
D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents
Fluocortolone Pivalate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids D000893 - Anti-Inflammatory Agents
1-[[2-(4-chlorophenyl)-5-methyl-4-oxazolyl]methyl]-N-[2-(dipropylamino)ethyl]-4-piperidinecarboxamide
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide
(6S,7R,8aR)-N-[6-(dimethylamino)hexyl]-6-[3-(2-hydroxyethoxy)phenyl]-1,4-dioxo-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-7-carboxamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide
2-cyclopropyl-1-[(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-(pyridin-4-ylmethyl)-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]ethanone
2-cyclopropyl-1-[(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-(pyridin-4-ylmethyl)-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]ethanone
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide
(2-hydroxy-3-phosphonooxypropyl) (11Z,14Z,17Z)-icosa-11,14,17-trienoate
[(4E,8E,12E)-2-acetamido-3-hydroxypentadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(4E,8E,12E)-3-hydroxy-2-(propanoylamino)tetradeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
(2E,4E,6E,8E,10E,12E,14E,16E,18E,20E,22E)-2,6,10,15,19,23-hexamethyltetracosa-2,4,6,8,10,12,14,16,18,20,22-undecaenedioic acid
4,4-diapolycopenedioic acid
An apo carotenoid triterpenoid that is 4,4-diapolycopene in which two of the terminal methyl groups have been oxidised to carboxy groups.
(4s)-4-[2,2-dimethyl-8-(3-methylbut-2-en-1-yl)-3,4-dihydro-1-benzopyran-6-yl]-12,12-dimethyl-3,11-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1,7,9-trien-6-one
7-hydroxy-2-[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]-6,8-bis(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
14-(acetyloxy)-2-hydroxy-4,9,13,17-tetramethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadeca-3,8,16-trien-12-yl butanoate
(8r,9s,10s)-8-ethoxy-3,4,5,14,15,16-hexamethoxy-9,10-dimethyltricyclo[10.4.0.0²,⁷]hexadeca-1(12),2,4,6,13,15-hexaene
[(2r,3r,3ar,5r,6r,7s,9bs,10ar)-2-(acetyloxy)-7-ethenyl-5,6-dihydroxy-3,7-dimethyl-4-oxo-1h,2h,3ah,5h,6h,8h,9h,10h,10ah-cyclopropa[f]phenanthren-3-yl]methyl 2-methylpropanoate
(1e,5r,10s,12z,14s,16r,17r,20s)-9-isopropyl-8,16-dimethoxy-2,5,13,16-tetramethyl-6,15,19-trioxatetracyclo[12.5.1.0⁵,¹⁰.0¹⁷,²⁰]icosa-1,8,12-triene-7,18-dione
(1s,2s,8s,11r,12r,15s)-1,2,8,15-tetramethyl-5,18-bis(propan-2-ylidene)pentacyclo[10.8.0.0²,¹¹.0³,⁹.0¹⁴,²⁰]icosa-3(9),14(20)-diene-6,10,13,17-tetrone
(4s)-3,8,9-trihydroxy-6-methyl-4,5,7-tris(3-methylbut-2-en-1-yl)-4h-anthracen-1-one
methyl (3e,3as,5ar,6r,7r,9ar,9br)-7-(acetyloxy)-3-[(3e)-5-methoxy-5-oxopent-3-en-2-ylidene]-3a,6,9a-trimethyl-2-oxo-octahydrocyclopenta[a]naphthalene-6-carboxylate
(1s,2s,8r,11r,12r,15s)-1,2,8,15-tetramethyl-5,18-bis(propan-2-ylidene)pentacyclo[10.8.0.0²,¹¹.0³,⁹.0¹⁴,²⁰]icosa-3(9),14(20)-diene-6,10,13,17-tetrone
1-[(1r,4as,11ar)-1-(acetyloxy)-7-methyl-11-methylidene-1h,4ah,5h,6h,9h,10h,11ah-cyclonona[c]pyran-4-yl]-3-(acetyloxy)-4-methylpent-4-en-1-yl acetate
[(1as,1bs,3r,3ar,5s,7br,9r,9ar)-3,9-bis(acetyloxy)-5,7b-dimethyl-5-[(2s)-oxiran-2-yl]-1h,1bh,2h,3h,3ah,4h,6h,8h,9h,9ah-cyclopropa[a]phenanthren-1a-yl]methyl acetate
3-[(15-hydroxyhexadecyl)oxy]-5-methyl-1h,8h,8ah-3λ⁵-furo[3,4-e][1,3,2]dioxaphosphepine-3,6-dione
[3,4-bis(acetyloxy)-1-[2-(furan-3-yl)ethyl]-2,4a,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]methyl acetate
(2r*,3s*,4r*,5r*,9s*,11s*,15r*)-3,5,15-triacetoxy-14-oxola-thyra-6(17),12e-diene
{"Ingredient_id": "HBIN006477","Ingredient_name": "(2r*,3s*,4r*,5r*,9s*,11s*,15r*)-3,5,15-triacetoxy-14-oxola-thyra-6(17),12e-diene","Alias": "NA","Ingredient_formula": "C26H36O7","Ingredient_Smile": "CC1CC2(C(C1OC(=O)C)C(C(=C)CCC3C(C3(C)C)C=C(C2=O)C)OC(=O)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21514","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5β-hydroxybufotalin
{"Ingredient_id": "HBIN011472","Ingredient_name": "5\u03b2-hydroxybufotalin","Alias": "NA","Ingredient_formula": "C26H36O7","Ingredient_Smile": "CC(=O)OC1CC2(C3CCC4(CC(CCC4(C3CCC2(C1C5=COC(=O)C=C5)C)C)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9860","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
9α-hydroxy-2α,10β,13α-triacetoxytaxa-4(20),5(6),11(12)-triene
{"Ingredient_id": "HBIN014045","Ingredient_name": "9\u03b1-hydroxy-2\u03b1,10\u03b2,13\u03b1-triacetoxytaxa-4(20),5(6),11(12)-triene","Alias": "NA","Ingredient_formula": "C26H36O7","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10780","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}